Omega-3 fatty acid supplements for cancer-associated weight loss.
Omega-3 fatty acids have been tested for the treatment of cancer anorexia/weight loss, a syndrome that predicts a poor prognosis among cancer patients with incurable disease. This review focuses on both the preclinical and clinical data of omega-3 fatty acids for treating this syndrome. Overall, the promise of the former does not seem to be borne out completely in the latter. This review includes a discussion of how these data might be interpreted and explained to cancer patients who are striving to cope with this syndrome.
Jatoi
Aminah
A
Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905-0002, USA. jatoi.aminah@mayo.edu
D002100:Cachexia / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D009369:Neoplasms / Q000150:complications* / Q000378:metabolism; D017410:Practice Guidelines as Topic; D015431:Weight Loss / Q000187:drug effects*
D015525:Fatty Acids, Omega-3